Corey Ostman Quotes (37 Quotes)

Underwriters are very careful now in how they bring their deals out. They're just waiting for the opportunity to bring their deals forward.

The main thing I'm looking at is I expect this to stay on the calendar. If it were a high-tech company it would be up in the air.

Odyssey is in wait-and-see mode. It's kind of unknown what the institutional demand will be.

They are coming out at the right time in the market.

We've seen a tremendous number of optical deals. But now we are seeing the end of the cycle of it being the hot sector.

Technology had a reasonably good run on the Nasdaq last weekend, but once again it's really wait and see how they price.

That's going to be the one to watch. If you look at college students, everyone's online.

I thought they would have a decent opening pop, but didn't expect anything this big. They are a real company, with real products.

Martha Stewart has been doing this for a long time. I don't think it's a fad.

Rigel is coming out at the worst possible time.

The dynamics of an IPO, especially one with the hype like this one, is always hard to predict right out of the gate. But this is a great company. It's one a lot of institutions are going to want to invest in.

Just because of Andreessen, this will get institutions interested.

This will be very interesting to watch. B2C is still very much out of favor.

Since we're coming out of a gap, we would like to see the deals stick with their price ranges. This would show they didn't lower their terms to get the institutions to bite.

Under normal circumstances, Multilink would be the one to watch. But semiconductors got hammered last week.

This is a real company, with a real product and real services. This isn't a speculative deal like a dot.com.

With no particular sector to provider leadership, it's hard to have a general trend.

The market is so cautious right now and so shaky that if you don't have all those perfect scenarios, then you will trade at your IPO price.

For a deal this size it's not unusual to price in the middle. What it means is that it's a solid deal and was priced accordingly.

This is not a good time right now for Nextel to come out.

I think just Friday's drop in the Nasdaq will make people skittish. It's really pretty light through March and not really stuff you can count on getting done.

Anything technology-related that is new is already seen with some skepticism and people are running away. It's a tough market right now.

Because Support.com is in the application market space, I thought people would be more conservative. This is a nice signal for traditional Internet deals currently in registration.

Health care has done really well.

Institutions are always interested in hearing about these sorts of deal. They could do reasonably well and see a moderate pop.

It has to do more with the standard of living than anything else. As the standard of living keeps growing, more people can afford these services, but how fast they will grow in China is anyone's guess.

They've been around for many years. Monsanto is a staple company with lots of fundamentals and an interesting deal.

I would expect Beacon to trade flat. I don't know if there's necessarily demand in the market for that, but if they boost their price range at least that will show institutional demand.

Diversity is good because you can tackle different geographic areas with a subset of properties.

It will be interesting to see if an online retailer can come into this market and get a good response. Everyone's heard of them but the question is whether they'll get the attention of the Street.

A lot of people still look toward a small start-up as having more potential than big companies. Internet infrastructure is still a very viable area in the IPO market.

AOL Latin America's price dropped pretty dramatically so we are assuming the institutions are not clamoring for the issue. There doesn't seem to be that much interest.

They're a very solid company and it looks like they're getting good demand.

It's very interesting to see a deal double in a really slow week like this. Because they produce components for high-growth segments of the market, this may have excited investors.

It's troubling in the long term because we saw the number of filings decrease in second quarter versus first quarter.

The market for tech deals is sort of on-again, off-again, so you've got to look at the fundamentals that they have decent revenue for a company this size.

It's a totally different kind of deal. It's not a high-tech company and that's kind of a good thing.